Intracellular transport of acid β-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)

Journal of Pathology

Volumn 188, Issue 4, 1999, Pages 407-414

  Zimmer, Klaus Peter ^a   Le Coutre, Philipp ^b   Aerts, Hans M F G ^c   Harzer, Klaus ^d   Fukuda, Minoru ^e   O'Brien, John S ^f   Naim, Hassan Y ^g  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Istituto Tumori   (Italy)

^c E C Slater Inst for Biochem Res   (Netherlands)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e BURNHAM INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Acid glucosidase; Cathepsin D; Gaucher's disease; Intracellular transport; LAMP 1; LAMP 2; Saposin C; Thin frozen section and immunogold technique

Indexed keywords

GLUCOSIDASE; GLUCOSYLCERAMIDASE; MEMBRANE PROTEIN;

ARTICLE; CASE REPORT; ENZYME ACTIVITY; GAUCHER DISEASE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; HUMAN; IMMUNOGOLD STAINING; INTRACELLULAR TRANSPORT; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEIN TRANSPORT;

EID: 0032798194     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z     Document Type: Article

References (35)

1. Beutler E. Gaucher disease: new molecular approaches to diagnosis and treatment. Science 1992; 256: 794-799.
2. Sidransky E, Bottler A, Strubblefield B, Ginns EI. DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype? Hum Mutat 1994; 3: 25-28.
3. Aerts JMFG, Donker-Koopman WE, Brul S, et al. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease. Biochem J 1990; 269: 93-100.
4. Grace M, Graves PN, Smith FI, Grabowski GA. Analyses of catalytic activity and inhibitor binding of human acid β-glucosidase by site-directed mutagenesis. J Biol Chem 1990; 265: 6827-6835.
5. Ohashi F, Hong CM, Weiler S, et al. Characterization of human glucocerebrosidase from different mutant alleles. J Biol Chem 1991; 266: 3661-3667.
6. Willemsen R, van Dongen JM, Ginns EI, et al. Ultrastructural localization of glucocerebrosidase in cultured Gaucher's disease fibroblasts by immunocytochemistry. J Neurol 1987; 234: 44-51.
7. Jonsson LMV, Murray GL, Sorrell SH, et al. Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts. Eur J Biochem 1987; 164: 171-179.
8. Morimoto S, Yamamoto Y, O'Brien JS, Kishimoto Y. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases. Proc Natl Acad Sci USA 1990; 87: 3493-3497.
9. Harter C, Mellman I. Transport of the lysosomal membrane glycoprotein Igp120 (Igp-A) to lysosomes does not require appearance on the plasma membrane. J Cell Biol 1992; 117: 311-325.
10. Beutler E, Gelbart T, West C. Identification of six new Gaucher disease mutations. Genomics 1993; 15: 203-205.
11. Beutler E, Gelbart T. Two new Gaucher disease mutations. Hum Genet 1994; 93: 209-210.
12. Harzer K. Enzymic diagnosis in 27 cases with Gaucher's disease. Clin Chim Acta 1980; 106: 9-15.
13. Van Weely S, van Leeuwen M, Jansen D, et al. Clinical genotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts. Biochim Biophys Acta 1991; 1096: 301-311.
14. Naim HY, Sterchi EE, Lentze MJ. Biosynthesis and maturation of lactase-phlorizin hydrolase in the human small intestinal epithelial cells. Biochem J 1987; 241: 427-434.
15. Zimmer KP, Matsuda I, Matsuura T, et al. Ultrastructural, immunocytochemical and stereological investigation of hepatocytes in a patient with the mutation of the ornithine transcarbamylase gene. Eur J Cell Biol 1995; 67: 73-83.
16. Zimmer KP, Naim HY, Koch HG, et al. Survival after early treatment for carbamyl phosphate synthetase (CPS) I deficiency associated with increase of intramitochondrial CPS I. Lancet 1995; 346: 1530-1531.
17. Barneveld RA, Tegelaers FPW, Ginns EI, et al. Monoclonal antibodies against human β-glucocerebrosidase. Eur J Biochem 1983; 134: 585-589.
18. Carlsson SR, Roth J, Filler F, Fukuda F. Isolation and characterization of human lysosomal membrane glycoproteins h-lamp 1 and h-lamp 2. J Biol Chem 1988; 263: 18911-18919.
19. O'Brien JS, Kretz KA, Dewji N, et al. Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus. Science 1988; 241: 1098-1101.
20. Beutler E, Demina A, Gelbart T. Glucocerebrosidase mutations in Gaucher disease. Mol Med 1994; 1: 82-92.
21. Grace ME, Desnick RJ, Pastores GM. Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurological type 2 Gaucher disease in non-Jewish patients. J Clin Invest 1997; 99: 2530-2537.
22. Bergmann JE, Grabowski GA. Posttranslational processing of human lysosomal acid b-glucosidase: a continuum of defects in Gaucher disease type 1 and type 2 fibroblasts. Am J Hum Genet 1989; 44: 741-750.
23. Van Weely S, Aerts JMFG, Van Leeuwen MB, et al. Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase. Eur J Biochem 1990; 191: 669-677.
24. Zhu X, Conner GE. Intermolecular association of lysosomal protein precursors during biosynthesis. J Biol Chem 1994; 269: 3846-3851.
25. Lippincott-Schwartz J, Fambrough D. Cycling of the integral membrane glycoprotein, LEP100 between plasma membrane and lysosomes: kinetic and morphological analysis. Cell 1987; 49: 669-677.
26. Reaves BJ, Bright NA, Mullock BM, Luzio JP. The effect of wortmannin on the localisation of lysosomal type I integral membrane glycoproteins suggests a role for phosphoinositide 3-kinase activity in regulating membrane traffic late in the endocytic pathway. J Cell Sci 1966; 109: 749-762.
27. Green SA, Zimmer K-P, Griffiths G, Mellman I. Kinetics of intracellular transport and sorting of lysosomal membrane and plasma membrane proteins. J Cell Biol 1987; 105: 1227-1240.
28. Höning S, Hunziker W. Cytoplasmic determinants involved in direct lysosomal sorting, endocytosis, and basolateral targeting of rat Igp120 (lamp-1) in MDCK cells. J Cell Biol 1995; 128: 321-332.
29. Griffiths G, Hoflack B, Simons K, et al. The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 1988; 52: 329-341.
30. Fujibayashi S, Wenger DA. Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts. J Biol Chem 1986; 261: 15339-15343.
31. Glickman JN, Kornfeld S. Mannose 6-phosphate-independent targeting of lysosomal enzymes in I-cell disease B lymphoblasts. J Cell Biol 1993; 123: 99-108.
32. Aerts JMFG, Schram AW, Strijland A, et al. Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation. Biochim Biophys Acta 1988; 964: 303-308.
33. Bartles JR, Feracci HM, Stieger B, Hubbard AL. Biogenesis of the rat hepatocyte plasma membrane in vivo: comparison of the pathways taken by apical and basolateral proteins using subcellular fractionation. J Cell Biol 1987; 105: 1241-1251.
34. 14C]L-glucosylceramide in rats. J Lipid Res 1987; 28: 968-972.
35. Platt FM, Neises GR, Reinkensmeier G, et al. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science 1997; 276: 428-431.